Vivos Therapeutics is a medical research and development company focused on breathing wellness.
Vivos Therapeutics has raised $2.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
Vivos Therapeutics's investors include Alliance Global Partners, Seneca Partners, Streeterville Capital.
Vivos Therapeutics is headquartered in Littleton, United States.
Vivos Therapeutics is a medical research and development company focused on breathing wellness.
Vivos Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vivos Therapeutics — Funding & Investors." VCBacked, April 7, 2026, https://www.vcbacked.co/company/vivos-therapeutics. Accessed September 30, 2026.
VCBacked. (2026). Vivos Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/vivos-therapeutics
{{cite web |title=Vivos Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vivos-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated